|
DERA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.899170E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.694000E-01 |
| Normal-vs-Stage2 |
3.602200E-01 |
| Normal-vs-Stage3 |
7.392000E-01 |
| Normal-vs-Stage4 |
7.700200E-01 |
| Stage1-vs-Stage2 |
5.820200E-01 |
| Stage1-vs-Stage3 |
7.510200E-01 |
| Stage1-vs-Stage4 |
9.264400E-01 |
| Stage2-vs-Stage3 |
5.188000E-01 |
| Stage2-vs-Stage4 |
7.124200E-01 |
| Stage3-vs-Stage4 |
9.183600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.723800E-01 |
| Normal-vs-AfricanAmerican |
7.405800E-02 |
| Normal-vs-Asian |
7.041400E-01 |
| Caucasian-vs-AfricanAmerican |
2.116400E-01 |
| Caucasian-vs-Asian |
7.309800E-01 |
| AfricanAmerican-vs-Asian |
9.317000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247810E-01 |
| Normal-vs-Female |
7.676000E-01 |
| Male-vs-Female |
3.507000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.483200E-01 |
| Normal-vs-Extreme_Weight |
6.870400E-01 |
| Normal-vs-Obese |
2.162600E-01 |
| Normal-vs-Extreme_Obese |
8.811000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.857600E-01 |
| Normal_Weight-vs-Obese |
1.705400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.997800E-01 |
| Extreme_Weight-vs-Obese |
4.322400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.774800E-01 |
| Obese-vs-Extreme_Obese |
6.710200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.975800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.231700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.641600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.179800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.512200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.917700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.352600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.184200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.246400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.491600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.180310E-02 |
| Normal-VS-Type2 PRCC |
8.602600E-01 |
| Normal-VS-KIRP CIMP |
4.598400E-01 |
| Normal-VS-Unclassified PRCC |
3.571000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.497800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.931200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.953000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.933400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.066200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.145600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.205600E-01 |
| Normal-vs-N1 |
6.205200E-01 |
| Normal-vs-N2 |
9.631700E-02 |
| N0-vs-N1 |
9.953800E-01 |
| N0-vs-N2 |
4.413400E-01 |
| N1-vs-N2 |
2.803800E-01 |
|
|
